FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo ...
Novo Nordisk has launched the first once-daily oral version of Wegovy, marking the arrival of the first GLP-1 weight-loss ...
A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from ...
The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for ...
However, the price of the 4 mg dose will rise to $199 a month from April 15, 2026, the company said. ・There are no ...
A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The ...
US officials have approved a daily pill version of Novo Nordisk’s injectable obesity drug Wegovy (semaglutide), opening the door to even more patients taking it. The “Wegovy pill”—cheaper than the ...